Partner Content Partner Content Juergen Knoebel from Roche speaks at the High Potent Medicin... Insights on HPAPI manufacturing
News FDA approves new uses for two Roche drugs FDA hands out new indications for Tecentriq and Lucentis.
News Roche’s Alecensa beats Xalkori in lung cancer head-to-head Roche’s new targeted lung cancer treatment Alecensa has shown itself to be superior to Pfizer’s established rival Xalkori in a head-to-head trial as a first line treatment.
News Roche keeps Rituxan evergreen with Breakthrough designation,... Roche is finding new ways to keep its oncology and rheumatoid arthritis blockbuster Ri
News Mylan expects first US Herceptin biosimilar launch Deal with Roche paves way for near-copy of breast cancer blockbuster
Oncology ASCO 2026: Powerful evidence for the microbiome in oncology,... Can the state of someone’s gut microbiome – the balance of good and bad bacteria in their digestive tract – affect their response to cancer immunother
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
